Prognostic significance of co-existent adenomyosis on outcomes and tumor characteristics of endometrial cancer: A meta-analysis

An M, Min An, Min Sung An, Duan H, Hua Duan, Ying Zhang
Journal of Obstetrics and Gynaecology Research · 2020 · vol. 46(9) , pp. 1851–1863 · doi:10.1111/jog.14371 · PMID:32686169 · W3043471992
Systematic review / meta-analysis OA: closed CC0 ⤵ 11 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This meta-analysis of 14 studies found that co-existent adenomyosis in endometrial cancer patients was associated with better overall survival and less aggressive tumor characteristics, suggesting a protective prognostic role.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: Published data on the impact of co-existent adenomyosis on the prognosis of patients with endometrial cancer remains elusive, with studies reporting conflicting results. We conducted this meta-analysis to evaluate the prognostic significance of co-existent adenomyosis on clinical outcomes and tumor characteristics of endometrial cancer patients. METHODS: A comprehensive literature review of multiple databases was conducted; quality assessment of eligible studies was performed by the Newcastle-Ottawa scale (NOS). The outcomes of interest were compared in endometrial cancer patients with or without adenomyosis. Hazards ratios (HR) and Odds ratios (OR) with 95% confidence interval (CI) were calculated as a measure of effects. RESULTS: Fourteen retrospective observational studies comprising 1308 endometrial cancer patients with adenomyosis and 3734 patients without adenomyosis were included in this meta-analysis. Results indicated that endometrial cancer patients with adenomyosis was significantly associated with an increased overall survival rate (HR = 0.51; 95% CI = 0.38-0.69; P < 0.00001), but not with disease-free survival rate (HR = 0.68; 95% CI = 0.30-1.53; P = 0.35); besides, significantly associated with decreased ratio of deep myometrial invasion (OR = 0.45; 95% CI = 0.33-0.60; P < 0.00001), lymphovascular space invasion (OR = 0.44; 95% CI = 0.29-0.68; P = 0.0002), an increased ratio of histological grade 1 (OR = 1.84; 95% CI = 1.34-2.53; P = 0.0002) and FIGO I-II (OR = 1.85; 95% CI = 1.49-2.30; P < 0.00001). However, there was no significant difference in pathological type and lymph node metastasis. There was a low to high heterogeneity with I2 ranging from 0 to 67%. CONCLUSION: This meta-analysis indicated that co-existent adenomyosis with endometrial cancer is associated with favorable tumor characteristics and could serve as a potential protective factor for the prognosis of endometrial cancer.

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Endometrial Neoplasms Endometrial Neoplasms Endometrial Neoplasms Endometrial Neoplasms Female Female Humans Humans Lymphatic Metastasis Lymphatic Metastasis Observational Studies as Topic Observational Studies as Topic Prognosis Prognosis Retrospective Studies Retrospective Studies

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (30)

Cited by (11)

Source provenance

europepmc
last seen: 2026-10-14T06:08:39.101224+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:28:03.990958+00:00
License: CC0 · commercial use OK